Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Connect with this vendor - Learn about this product

XELEAC 20MG - Doxorubicin Hydrochloride Liposome Injection 20mg/10ml



Medicine composition: Doxorubicin Hydrochloride Liposome Injection 20mg

Dosage Form: Vial

Packing: 1 Vial

Market Authorization: MBA Pharmaceuticals Pvt Ltd

Country Of Origin: India

Similar to Doxil/Lippod/Lipodox


Doxorubicin Hydrochloride Liposomal

As monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk.

For treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen.

In combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant.

For treatment of AIDS-related Kaposi's sarcoma (KS) in patients with low CD4 counts (< 200 CD4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease.